Promotions & Moves

TFS Appoints Chief Commercial Officer

Copestake brings more than 25 years of experience in the pharmaceutical, biotechnology and CRO industries

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Dr. Andrew Copestake has been appointed chief commercial officer and executive vice president, Global Business Development, TFS International. Dr. Copestake is an entrepreneurial, commercially focused, senior executive with more than 25 years of experience in the pharmaceutical, biotechnology and CRO industries. Dr. Copestake will be based out of the TFS offices in London.   He most recently served as chief business development officer at Julius Clinical, a CRO based in the Netherlands. Previo...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters